Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Ophth. Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Ophth. Other
    FDA Approves Triamcinolone Acetone Formulation for Ocular Use - (DGNews)
    Adalimumab Cuts Uveitis Flares: Presented at EULAR - (DGDispatch)
    Diabetes Medication Associated With Slower Progression of Retina Disease - (DGNews)
    Patients With Graves' Disease Treated With Radioiodine I-131 at Risk of Graves' Ophthalmology: Presented at ECE - (DGDispatch)
    More Patients With Macular Degeneration Driving Their Cars After Treatment With Ranibizumab Than With Photodynamic Therapy: Presented at ARVO - (DGDispatch)

    News archive

     Recent webcasts/CME - Ophth. Other
    • Data Continue to Modify Guidelines for Immunomodulatory Therapy in Multiple Sclerosis
    • Targeted Therapies Demonstrate Efficacy in Multiple Sclerosis
    • Use of Monoclonal Antibodies in Multiple Sclerosis: Balancing Efficacy and Safety Considerations
    • Combination Therapies for the Treatment of AMD
      Managing Concomitant Eye Diseases: Expert Views on Glaucoma and Dry Eye

      Webcasts/CME archive

       Recent cases - Ophth. Other
        An Atypical Presentation of Cystic Fibrosis: A Case Report
        Lateral Rectus Metastasis from an Occult Systemic Malignancy Masquerading as Abducens Palsy: A Case Report
        Spontaneous Resolution of Congenital Brown's Syndrome - A Case Report
        Use of Intravitreal Bevacizumab in a Patient with a Von Hippel-Lindau-Associated Retinal Haemangioblastoma of the Optic Nerve Head: A Case Report
        Clear Lens Phacoemulsification in Anterior Lenticonus Due to Alport Syndrome: Two Case Reports

        Cases archive
          




        my personal edition > ophth. other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        High-Dose Vitamins May Boost Macular Health: Presented at AAO

        By K.L. Capozza

        LAS VEGAS, NV -- November 16, 2006 -- A small study of high-dose dietary supplementation with beta carotene, vitamin C, vitamin E, zinc, copper, lutein, and zeaxanthin shows a potential way to improve macular health in patients with dry age-related macular degeneration (DAMD).

        The findings were presented here on November 14th at the American Academy of Ophthalmology Annual Meeting (AAO).

        In a controlled pilot study of 20 patients, researchers led by John O. Mason, III, MD, associate professor of ophthalmology, University of Alabama Callahan Eye Foundation Hospital, Birmingham, Alabama, evaluated the effect of this vitamin cocktail on patients with advanced DAMD, a leading cause of blindness in the United States.

        The researchers compared 10 control eyes with 10 eyes placed on daily high-dose supplements containing 10,000 IU vitamin A, 125 mg vitamin C, 100 IU vitamin E, 55 mg zinc, 2 mg copper, 10 mg lutein, and 440 mg zeaxanthin.

        A multifocal electroretinogram was used to gauge the overall health of the macula at baseline and 2 months after the start of vitamin supplementation. In addition, patients' visual acuity was recorded at baseline and at follow-up.

        Results showed that the electroretinogram recordings from patients in the supplementation group showed a statistically significant improvement from baseline to the 3-month follow-up but remained unchanged in the control group.

        In addition, visual acuity in patients on daily supplements showed a mean 3.1 letters of improvement at 3 months of follow-up but did not change in the control group.

        "Nutritional supplements offer the greatest hope for slowing the progression of this debilitating disease that robs patients of their visual function and quality of life," said Dr. Mason and colleagues in a written statement.

        The results, while intriguing, are highly preliminary and the study did not shed light on which ingredient (or ingredients) in the vitamin cocktail might be responsible for the effect.

        The study was funded by Macular Health, LLC.


        [Presentation title: Multifocal Electroretinogram Study of Patients Placed on Supplemental Vitamins, Minerals, and Carotenoids for Dry Macular Degeneration. Abstract PO716]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send